Stock CDIO CARDIO DIAGNOSTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Cardio Diagnostics Holdings, Inc.

Equities

CDIO

US14159C1036

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 11:14:43 2025-01-15 EST 		5-day change 1st Jan Change
0.5900 USD +3.40% Intraday chart for Cardio Diagnostics Holdings, Inc. -18.52% -35.11%
11-13 Cardio Diagnostics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
08-12 Cardio Diagnostics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI

Business description: Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Number of employees: 8

Sales by Activity: Cardio Diagnostics Holdings, Inc.

Fiscal Period: December2020202120222023

Diagnostic Kits / Equipment

- 901 950 17.06K
See all business segments

Geographical breakdown of sales: Cardio Diagnostics Holdings, Inc.

Fiscal Period: December2020202120222023

United States

- 901 950 17.06K
See all geographic segments

Managers: Cardio Diagnostics Holdings, Inc.

Director TitleAgeSince
Meeshanthini Dogan CEO
 Chief Executive Officer 36 2022-10-24
Elisa Luqman DFI
 Director of Finance/CFO 60 2022-10-24
Timur Dogan CTO
 Chief Tech/Sci/R&D Officer 37 2022-10-24
Robert Philibert CTO
 Chief Tech/Sci/R&D Officer 64 2022-10-24
Gene Mannheimer IRC
 Investor Relations Contact - -
See CARDIO DIAGNOSTICS HOLDINGS, INC. governance

Members of the board: Cardio Diagnostics Holdings, Inc.

Manager TitleAgeSince
Meeshanthini Dogan BRD
 Director/Board Member 36 2022-10-24
Robert Philibert BRD
 Director/Board Member 64 2022-10-24
Warren Hosseinion CHM
 Chairman 53 2022-10-24
James Intrater BRD
 Director/Board Member 61 2022-10-24
Paul Burton BRD
 Director/Board Member - 2023-12-20
Composition of the Board of Directors

Shareholders: Cardio Diagnostics Holdings, Inc.

NameEquities%Valuation
Robert Philibert
4.164 %
1,683,867 4.164 % 2 M $
Meeshanthini Dogan
4.094 %
1,655,420 4.094 % 2 M $
BlackRock Institutional Trust Co. NA
2.639 %
1,067,062 2.639 % 1 M $
Vanguard Group, Inc. (Subfiler)
0.5740 %
232,139 0.5740 % 232 139 $
Geode Capital Management LLC
0.4560 %
184,409 0.4560 % 184 409 $
NameEquities%Valuation
Walleye Capital LLC
-
234,907 - 19 497 $
EdgeHill Partners
-
228,952 - 19 003 $
Saba Capital Management LP
-
199,839 - 16 587 $
Walleye Trading LLC
-
132,265 - 10 978 $
Clear Street LLC
-
83,042 - 6 892 $
List of CARDIO DIAGNOSTICS HOLDINGS, INC. shareholders

Company details: Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc.

311 West Superior Street Suite 444

60654, Chicago

+

http://www.cardiodiagnosticsinc.com
address Cardio Diagnostics Holdings, Inc.(CDIO)

Bio Therapeutic Drugs

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
CARDIO DIAGNOSTICS HOLDINGS, INC. Stock Cardio Diagnostics Holdings, Inc.
+3.40%-18.52%-76.76%-93.97%23.07M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+2.29%+2.19%-3.74%+82.25%106B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.19%-4.68%-25.40%+14.40%74.33B
ARGENX SE Stock argenx SE
-2.17%-0.19%+83.97%+149.11%40.62B
BIONTECH SE Stock BioNTech SE
+2.12%-6.07%+15.23%-32.20%26.95B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-3.13%+1.72%-25.81%-53.25%21.45B
BEIGENE, LTD. Stock BeiGene, Ltd.
+0.44%+13.31%+16.33%-15.89%21.42B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+0.95%+1.59%+6.25%+89.14%14.12B
GENMAB A/S Stock Genmab A/S
-5.68%-7.53%-28.72%-35.95%13.79B
SUMMIT THERAPEUTICS INC. Stock Summit Therapeutics Inc.
+5.32%-6.80%+406.94%+679.56%12.28B
Average +0.57%-3.79%+36.83%+78.32% 33.1B
Weighted average by Cap. +0.76%-0.65%+18.18%+68.28%
See all sector performances

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Ratings

Trading Rating
Investor Rating
ESG MSCI
surperformance-ratings-light-chart CARDIO-DIAGNOSTICS-HOLDINMore Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5706USD
Average target price
2.000USD
Spread / Average Target
+250.51%
Consensus
Profit revisions
estimates-change-chart CARDIO-DIAGNOSTICS-HOLDIN Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart CARDIO-DIAGNOSTICS-HOLDIN Company calendar

Income Statement and Estimates

income-statement-evolution-chart CARDIO-DIAGNOSTICS-HOLDIN More financial data
  1. Stock Market
  2. Equities
  3. CDIO Stock
  4. Company Cardio Diagnostics Holdings, Inc.
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition